Stanford Research

U.S. Medicine: Magnesium–Ibogaine Therapy Could Offer Treatment Option for TBI

Summarizes the Nature Mental Health study for a veteran/clinical audience, emphasizing rapid changes in brain activity after treatment. It includes comments from lead author Jennifer Lissemore about why the team studied ibogaine’s effects on brain function.

Military.com: Veteran Executive Order a Win for Ibogaine, But More Research Needed

Mentions the newer MRI findings showing increased cortical thickness after magnesium–ibogaine treatment. It places the study in the context of veteran advocacy and the need for more rigorous ibogaine research.

PsyPost: A dream-like psychedelic might help traumatized veterans reset their brains

Covers the Journal of Affective Disorders paper showing that stronger mystical experiences during magnesium–ibogaine were associated with larger symptom reductions. It frames the subjective experience as a possible contributor to therapeutic benefit.

Smithsonian Magazine: A Lesser-Known Psychedelic Drug Shows Promise for PTSD Treatment

Ibogaine, derived from a central African shrub, has been used in rituals for two millennia. But in a small study, it appeared to reduce symptoms of PTSD among veterans

Healthline: Psychedelic Ibogaine May Help PTSD and Depression After Traumatic Brain Injury